Alacrita, the rapidly growing life science consultancy, has established an IP practice to provide analysis, assessment and advice on life science IP. The practice is focussed on both helping clients extract maximum value from their IP portfolios and supporting companies and investors conducting IP due diligence.
The service is designed to sit alongside that offered by established patent firms. Alacrita does not file and maintain patents but rather provides high level strategic advice. For example, patent applications and procedures can take on a life of their own, with organisational inertia masking the need for a decision. Alacrita can provide a realistic, commercially relevant reality check, helping clients rationalise and prioritise IP assets.
Jo Davies, a European and Chartered Patent Attorney, will lead the practice. Jo has worked in Intellectual Property since 1983 and was a Partner in the Patent Attorney firm Reddie & Grose for 21 years from 1988 to 2009. His technical areas of expertise span pharmaceutical chemistry, pharmacology, microbiology, biotechnology, genetic engineering, physiology, pharmacogenomics, proteomics, plant and animal protection, medtech and medical instruments.
An IP Whitepaper, available for download through the link below, describes the threat of contributory infringement by originators whose products are being ‘re-profiled’.